Clifton Insight is a network of academic researchers working as consultants in evidence synthesis and health economics to world leading pharmaceutical companies and health economic consulting companies. We were founded in 2014 in Bristol by Dr Howard Thom, who is still our Director. Our team of roughly 10 people hold positions at Universities across the UK but are primarily based in Bristol. We have provided expert advice and analytic support on dozens of health technology submissions to both UK and international payers, including the National Institute of Health and Care Excellence. Our involvement ranges from advising on reviews and analysis to conducting every aspect of a submission, from systematic literature reviews to economic models.
Our team are all involved in pathbreaking applied and methodological research across the spectrum of health technology assessment. Topics on which we have developed new methods include automating systematic reviews, disconnected networks in network meta-analysis, survival outcomes network meta-analysis, population adjusted indirect comparison, multistate modelling, structural uncertainty in cost-effectiveness models, and value of information analysis. Our applied research has been across a wide range of diseases, covering rheumatology, dermatology, psychiatry, cardiology, neurology, oncology, and haematology. We are excited to bring this expertise to bear on your problems in health economics and outcomes research.
We are happy to advise on analyses conducted in-house or by other vendors, or to lead on all or specific aspects of submissions to healthcare payers. We are actively expanding our group of research partners – get in touch today to explore how we can work together.